Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03989882 · ClinicalTrials.gov registry record · NA
Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults
A NA study, sponsored by Oklahoma State University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03989882 is a NA study that has completed, run by Oklahoma State University. The registered enrollment target is 42 participants.
The verdict
NCT03989882, a NA study, has completed, sponsored by Oklahoma State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The objective of this pilot study is to determine the effects of wheat germ (WG) supplementation on gut health and subsequent effects on markers of inflammation and insulin resistance in overweight individuals. WG is a by-product of wheat processing and an excellent source of omega-3 fatty acids, vitamin E, and fiber. A few studies have shown the health benefits of WG including gut modulatory potential, but the prebiotic functions of WG in humans remain in question and warrant further investigation.
Interventions
- OTHER Control
- OTHER Wheat germ energy ball
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03989882
The ClinicalTrials.gov registry entry for NCT03989882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03989882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03989882 about?
NCT03989882 is a clinical study titled "Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults". The objective of this pilot study is to determine the effects of wheat germ (WG) supplementation on gut health and subsequent effects on markers of inflammation and insulin resistance in overweight individuals. WG is a by-product of wheat processing and an excellent source of omega-3 fatty acids, vi...
What is the current status of trial NCT03989882?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2019-05-28. Estimated completion is 2021-11-30.
What interventions are being tested in trial NCT03989882?
The interventions under investigation include: Control (OTHER), Wheat germ energy ball (OTHER).
Who is sponsoring clinical trial NCT03989882?
This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.